Evidence map›Paper›PMID 34594038›Full record

ArticleNature genetics2021

Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response.

Kevin C Johnson, Kevin J Anderson, Elise T Courtois, Amit D Gujar, Floris P Barthel, Frederick S Varn, Diane Luo, Martine Seignon, Eunhee Yi, Hoon Kim and 13 more

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 191 papers.

0numbers the graph read from it
0cells of the map it votes in
191citing papers in PubMed
15.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

191 citing papers in PubMed, 251 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Hp1bp3 loss links chromatin reorganization to metabolic vulnerability in glioma.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

131 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 3 countries.

Kevin C Johnson *The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. kevin.c.johnson@jax.org.ORCID http://orcid.org/0000-0003-0016-5158
Kevin J Anderson *The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.ORCID http://orcid.org/0000-0002-2362-273X
Elise T CourtoisThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.ORCID http://orcid.org/0000-0002-8749-2719
Amit D GujarThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.ORCID http://orcid.org/0000-0003-0689-6680
Floris P BarthelThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.ORCID http://orcid.org/0000-0002-7425-4180
Frederick S VarnThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.ORCID http://orcid.org/0000-0001-6307-016X
Diane LuoThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Martine SeignonThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Eunhee YiThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.ORCID http://orcid.org/0000-0002-7839-7795
Hoon KimThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.ORCID http://orcid.org/0000-0003-4244-6126
Marcos R H EstecioDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Dacheng ZhaoThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Ming TangDepartment of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
Nicholas E NavinDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-2106-8624
Rahul MauryaThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Chew Yee NganThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Niels VerburgDepartment of Neurosurgery, Brain Tumor Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Philip C de Witt HamerDepartment of Neurosurgery, Brain Tumor Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Ketan BulsaraDivision of Neurosurgery, The University of Connecticut Health Center, Farmington, CT, USA.
Michael L SamuelsThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Sunit DasArthur and Sonia Labatt Brain Tumour Research Centre, Hospital for SickKids, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-2146-4168
Paul RobsonThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.ORCID http://orcid.org/0000-0002-0191-3958
Roel G W VerhaakThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. roel.verhaak@jax.org.ORCID http://orcid.org/0000-0003-2773-0436
Jackson Laboratory · USThe University of Texas MD Anderson Cancer Center · USVrije Universiteit Amsterdam · NLAmsterdam Neuroscience · NLDana-Farber Cancer Institute · USSt. Michael's Hospital · CAUConn Health · USUniversity of Connecticut · US

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI Anna Karolina Palucka · 1985 to 2026
$61.9M
Extrachromosomal DNA as a Targetable Mechanism in GlioblastomaR01CA237208 · NCI · YALE UNIVERSITY · PI VERHAAK, ROEL GW · 2020 to 2024
$2.5M
Genetic and Epigenetic Strategies for the Acquisition of Telomere Maintenance in Human Cancer CellsR00CA226387 · NCI · TRANSLATIONAL GENOMICS RESEARCH INST · PI BARTHEL, FLORIS · 2021 to 2023
$737k
Modeling Tumor Evolution in GliomaR21NS114873 · NINDS · JACKSON LABORATORY · PI VERHAAK, ROEL GW · 2019 to 2020
$520k
Genetic and Epigenetic Strategies for the Acquisition of Telomere Maintenance in Human Cancer CellsK99CA226387 · NCI · JACKSON LABORATORY · PI BARTHEL, FLORIS · 2018 to 2021
$250k
NCI NIH HHS K99 CA226387NCI NIH HHS P30 CA034196NCI NIH HHS R00 CA226387NCI NIH HHS R01 CA237208NINDS NIH HHS R21 NS114873
6 · The paper itself

Abstract

Glioma intratumoral heterogeneity enables adaptation to challenging microenvironments and contributes to therapeutic resistance. We integrated 914 single-cell DNA methylomes, 55,284 single-cell transcriptomes and bulk multi-omic profiles across 11 adult IDH mutant or IDH wild-type gliomas to delineate sources of intratumoral heterogeneity. We showed that local DNA methylation disorder is associated with cell-cell DNA methylation differences, is elevated in more aggressive tumors, links with transcriptional disruption and is altered during the environmental stress response. Glioma cells under in vitro hypoxic and irradiation stress increased local DNA methylation disorder and shifted cell states. We identified a positive association between genetic and epigenetic instability that was supported in bulk longitudinally collected DNA methylation data. Increased DNA methylation disorder associated with accelerated disease progression and recurrently selected DNA methylation changes were enriched for environmental stress response pathways. Our work identified an epigenetically facilitated adaptive stress response process and highlights the importance of epigenetic heterogeneity in shaping therapeutic outcomes.

Indexed as

Epigenesis, GeneticSingle-Cell AnalysisBrain NeoplasmsCell PlasticityClonal EvolutionDNA Copy Number VariationsDNA MethylationGene Expression Regulation, NeoplasticGenetic HeterogeneityGenome, HumanGliomaHumansMutationPhylogenyPromoter Regions, GeneticStress, Physiological

Identifiers

PMID34594038
PMCPMC8570135
OpenAlexW3202738945

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.